Life Science Company News

Results 21 - 40 out of 500 displayed.
«  1 2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 23 Feb 2024

Celularity Announces 1-for-10 Reverse Stock Split

Read more ››
By: GlobeNewswire - 23 Feb 2024

Coherus BioSciences Announces New Employment Inducement Grants

Read more ››
By: GlobeNewswire - 23 Feb 2024

Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab

Read more ››
By: GlobeNewswire - 23 Feb 2024

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Read more ››
By: GlobeNewswire - 23 Feb 2024

China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split

Read more ››
By: PR Newswire Association LLC. - 23 Feb 2024

Mastering The Meno(Pause) Transition Summit 3.0: A New Dawn in Women's Health

Read more ››
By: PR Newswire Association LLC. - 23 Feb 2024

Global Nano Calcium Carbonate Strategic Business Report 2024-2030: Increase in Plastic Production & Consumption Sets the Tone for Nano CaCO3 Consumption

Read more ››
By: PR Newswire Association LLC. - 23 Feb 2024

Global Exoskeleton Robots Business Report 2024-2030: As Defense Departments Lean towards Advanced Technologies, Opportunities Galore for Military Exoskeleton Robots

Read more ››
By: PR Newswire Association LLC. - 23 Feb 2024

Castellum, Inc. Announces Closing of $4 Million Revolver with Live Oak Bank

Read more ››
By: GlobeNewswire - 23 Feb 2024

BioCryst Presents New Real-world Data Showing Rapid, Substantial and Sustained HAE Attack Rate Reductions After Beginning ORLADEYO® (berotralstat) Treatment

Read more ››
By: GlobeNewswire - 23 Feb 2024

Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMP

Read more ››
By: GlobeNewswire - 23 Feb 2024

Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatment of IgA Nephropathy

Read more ››
By: GlobeNewswire - 23 Feb 2024

Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder

Read more ››
By: GlobeNewswire - 23 Feb 2024

TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2023 Financial Results and Business Update

Read more ››
By: GlobeNewswire - 23 Feb 2024

Ocuphire Pharma to Present in the BIO CEO & Investor Conference

Read more ››
By: GlobeNewswire - 23 Feb 2024

Gamida Cell Data Presented at the 2024 Tandem Meetings of ASTCT® and CIBMTR®

Read more ››
By: GlobeNewswire - 23 Feb 2024

Venus Concept Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Read more ››
By: GlobeNewswire - 23 Feb 2024

Jasper Therapeutics Presents Data from Preclinical Briquilimab Studies at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting

Read more ››
By: GlobeNewswire - 23 Feb 2024

Biodexa Announces Positive Top Line Phase I Clinical Trial Results for Diffuse Midline Glioma and Provides R&D Update

Read more ››
By: GlobeNewswire - 23 Feb 2024
Results 21 - 40 out of 500 displayed.
«  1 2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate